Market Share of Genomic Biomarkers Industry
The Genomic Biomarkers Market is highly competitive owing to the presence of large number of competitors. To sustain and increase footprints in such a competitive landscape, major players are adopting a lot of strategies such as product innovations, expansions, technology upgrades, investments in R&D as well as mergers and acquisitions. In 2018, BioMrieux SA completed the acquisition of Astute Medical to have access to biomarkers in the product pipeline of Astute Medical.
Major players currently in the market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Myriad Genetics Inc, Eurofins Scientific, QIAGEN etc.
Genomic Biomarkers Market Leaders
-
Thermo Fisher Scientific Inc.
-
F. Hoffmann-La Roche Ltd
-
Myriad Genetics Inc
-
Eurofins Scientific
-
QIAGEN
*Disclaimer: Major Players sorted in no particular order
